Skip to content

The steps taken: Why clinical trials have a diversity problem

European Pharmaceutical Manufacturer editor Reece Armstrong looks at the issue of diversity in clinical trials and how medicines aren't developed with every patient in mind.

The steps taken: Why clinical trials have a diversity problem
Published: | 2 min read

European Pharmaceutical Manufacturer editor Reece Armstrong looks at the issue of diversity in clinical trials and how medicines aren't developed with every patient in mind.

Diversity

At a time of global upheaval, when marginalised voices are sounding out across the world, it’s important that we listen to what’s being said.

It’s also important that we look to the industries we work in and understand how we can be better, how we can support those calling out for it, and how we can affect real change in both small ways and large.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information